Breaking News Instant updates and real-time market news.

KR

Kroger

$33.95 /

+0.55 (+1.65%)

06:05
02/16/21
02/16
06:05
02/16/21
06:05

Kroger partners with Gauss to provide smartphone-enabled COVID-19 home tests

Kroger Health, the health care division of Kroger, announced plans to offer the first smartphone-enabled, at-home Gauss COVID-19 Rapid Antigen Test Kit to patients nationwide. The new at-home testing solution, which is currently awaiting FDA Emergency Use Authorization, or EUA, will offer access to testing technology developed by Gauss. Once authorized, it will be the first rapid COVID-19 test that can be fully performed using only a smartphone and a lateral flow assay, without involving a laboratory, a telemedicine visit or any specialized electronics. Last month, Gauss produced its first 1.5M tests, which will be available for immediate distribution when the test receives EUA from the FDA, and the company has the capability to produce up to 30M tests per month. Kroger Health expects the at-home rapid antigen test will be available to purchase on Kroger.com and over the counter at its 2,200 pharmacies nationwide.

KR Kroger
$33.95 /

+0.55 (+1.65%)

01/28/21 Telsey Advisory
Kroger downgraded to Market Perform from Outperform at Telsey Advisory
01/20/21 Morgan Stanley
Albertsons downgraded to Underweight with $13 price target at Morgan Stanley
01/20/21 Morgan Stanley
Kroger downgraded to Underweight at Morgan Stanley
01/20/21 Morgan Stanley
Kroger downgraded to Underweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

Conference/Events
Achilles Therapeutics management to meet virtually with Oppenheimer » 16:20
09/20/21
09/20
16:20
09/20/21
16:20
ACHL

Achilles Therapeutics

$5.83 /

+0.005 (+0.09%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHL Achilles Therapeutics
$5.83 /

+0.005 (+0.09%)

ACHL Achilles Therapeutics
$5.83 /

+0.005 (+0.09%)

08/10/21 Piper Sandler
Achilles Therapeutics price target lowered to $23 from $25 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
04/26/21 BofA
BofA starts Achilles Therapeutics at Buy on 'unique' cancer platform
ACHL Achilles Therapeutics
$5.83 /

+0.005 (+0.09%)

  • 31
    Mar
ACHL Achilles Therapeutics
$5.83 /

+0.005 (+0.09%)

Options
Closing CBOE SPX and VIX Index summary for September 20th » 16:20
09/20/21
09/20
16:20
09/20/21
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

Conference/Events
Incyte management to meet virtually with Oppenheimer » 16:19
09/20/21
09/20
16:19
09/20/21
16:19
INCY

Incyte

$75.93 /

-0.1 (-0.13%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$75.93 /

-0.1 (-0.13%)

INCY Incyte
$75.93 /

-0.1 (-0.13%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
09/01/21 Cowen
Odds of Incyte drug exclusion from class warning 'largely unchanged,' says Cowen
07/20/21 Benchmark
Incyte upgraded to Buy from Hold at Benchmark
INCY Incyte
$75.93 /

-0.1 (-0.13%)

INCY Incyte
$75.93 /

-0.1 (-0.13%)

INCY Incyte
$75.93 /

-0.1 (-0.13%)

INCY Incyte
$75.93 /

-0.1 (-0.13%)

Hot Stocks
Willdan Group awarded $21.2M contract from City of Dublin, California » 16:19
09/20/21
09/20
16:19
09/20/21
16:19
WLDN

Willdan Group

$35.57 /

+0.49 (+1.40%)

Willdan Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WLDN Willdan Group
$35.57 /

+0.49 (+1.40%)

WLDN Willdan Group
$35.57 /

+0.49 (+1.40%)

08/06/21 Roth Capital
Willdan Group price target lowered to $45 from $58 at Roth Capital
03/10/21 Roth Capital
Willdan Group price target raised to $58 from $43 at Roth Capital
Hot Stocks
Aprea Therapeutics jumps 15% to $5.60 per share after announcing APR-246 data  16:18
09/20/21
09/20
16:18
09/20/21
16:18
APRE

Aprea Therapeutics

$4.84 /

-0.275 (-5.38%)

 
ShowHide Related Items >><<
APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

08/20/21 JPMorgan
JPMorgan downgrades Aprea to Underweight on 'multiple overhangs'
08/20/21 JPMorgan
Aprea Therapeutics downgraded to Underweight from Neutral at JPMorgan
08/16/21 Berenberg
Aprea Therapeutics downgraded to Hold from Buy at Berenberg
08/16/21 H.C. Wainwright
Aprea Therapeutics price target lowered to $4 from $6 at H.C. Wainwright
APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

Conference/Events
Pfizer management to meet virtually with Oppenheimer » 16:18
09/20/21
09/20
16:18
09/20/21
16:18
PFE

Pfizer

$44.22 /

+0.325 (+0.74%)

Meeting to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$44.22 /

+0.325 (+0.74%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
PFE Pfizer
$44.22 /

+0.325 (+0.74%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

Hot Stocks
Aprea Therapeutics presents data from phase 1/2 trial of APR-246 in solid tumors » 16:18
09/20/21
09/20
16:18
09/20/21
16:18
APRE

Aprea Therapeutics

$4.84 /

-0.275 (-5.38%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

08/20/21 JPMorgan
JPMorgan downgrades Aprea to Underweight on 'multiple overhangs'
08/20/21 JPMorgan
Aprea Therapeutics downgraded to Underweight from Neutral at JPMorgan
08/16/21 Berenberg
Aprea Therapeutics downgraded to Hold from Buy at Berenberg
08/16/21 H.C. Wainwright
Aprea Therapeutics price target lowered to $4 from $6 at H.C. Wainwright
APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

Hot Stocks
Verrica Pharmaceuticals receives CRL from FDA identifying deficiencies at CMO » 16:17
09/20/21
09/20
16:17
09/20/21
16:17
VRCA

Verrica Pharmaceuticals

$12.01 /

-0.045 (-0.37%)

Verrica Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

06/17/21 Needham
Verrica Pharmaceuticals's Ycanth offers superior efficacy to Novan, says Needham
06/01/21 Northland
Verrica Pharmaceuticals price target lowered to $19 from $24 at Northland
05/13/21 RBC Capital
Verrica Pharmaceuticals initiated with an Outperform at RBC Capital
03/08/21 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $24 from $21 at H.C. Wainwright
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

  • 23
    Mar
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

Technical Analysis
NASDAQ market internals summary » 16:17
09/20/21
09/20
16:17
09/20/21
16:17
$NSD

NASDAQ Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Hot Stocks
APA Corp. raises quarterly dividend to 6.25c per share » 16:16
09/20/21
09/20
16:16
09/20/21
16:16
APA

APA Corp.

$18.92 /

-1.215 (-6.03%)

The dividend on APA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APA APA Corp.
$18.92 /

-1.215 (-6.03%)

APA APA Corp.
$18.92 /

-1.215 (-6.03%)

07/20/21 Truist
APA Corp. price target lowered to $20 from $24 at Truist
06/25/21
Fly Intel: Top five analyst downgrades
06/25/21 JPMorgan
APA downgraded to Neutral ahead of appraisal results at JPMorgan
06/25/21 JPMorgan
APA Corp. downgraded to Neutral from Overweight at JPMorgan
APA APA Corp.
$18.92 /

-1.215 (-6.03%)

APA APA Corp.
$18.92 /

-1.215 (-6.03%)

APA APA Corp.
$18.92 /

-1.215 (-6.03%)

Conference/Events
Perion Network management to meet virtually with Oppenheimer » 16:16
09/20/21
09/20
16:16
09/20/21
16:16
PERI

Perion Network

$17.97 /

-0.99 (-5.22%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PERI Perion Network
$17.97 /

-0.99 (-5.22%)

08/03/21 Lake Street
Perion Network price target raised at Lake Street after 'well-executed quarter'
07/01/21 Needham
Perion Network price target raised to $25 from $21 at Needham
06/28/21 Stifel
Perion Network price target raised to $21 at Stifel after preliminary Q2 report
06/28/21 Lake Street
Perion Network price target raised to $29 at Lake Street after pre-announcement
PERI Perion Network
$17.97 /

-0.99 (-5.22%)

  • 20
    Jan
PERI Perion Network
$17.97 /

-0.99 (-5.22%)

PERI Perion Network
$17.97 /

-0.99 (-5.22%)

Hot Stocks
Axalta Coating withdraws FY21 guidance amid supply chain shortages » 16:16
09/20/21
09/20
16:16
09/20/21
16:16
AXTA

Axalta Coating

$27.96 /

-0.61 (-2.14%)

Axalta Coating Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

09/15/21 BofA
Axalta Coating removed from US 1 List at BofA
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
07/28/21 Deutsche Bank
Axalta Coating price target lowered to $36 from $38 at Deutsche Bank
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

Technical Analysis
NYSE market internals summary » 16:16
09/20/21
09/20
16:16
09/20/21
16:16
$NYE

NYSE Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Upgrade
Segro upgraded to Conviction Buy from Buy at Goldman Sachs » 16:15
09/20/21
09/20
16:15
09/20/21
16:15
SEGXF

Segro

$17.36 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEGXF Segro
$17.36 /

+ (+0.00%)

SEGXF Segro
$17.36 /

+ (+0.00%)

09/01/21 Morgan Stanley
Segro price target raised to 1,350 GBp from 1,100 GBp at Morgan Stanley
08/04/21 JPMorgan
Segro price target raised to 1,250 GBp from 1,195 GBp at JPMorgan
08/02/21 Barclays
Segro price target raised to 1,335 GBp from 1,220 GBp at Barclays
08/02/21 RBC Capital
Segro price target raised to 1,100 GBp from 875 GBp at RBC Capital
Hot Stocks
FedEx Express, FedEx Ground, and FedEx Freight to increase shipping rates » 16:15
09/20/21
09/20
16:15
09/20/21
16:15
FDX

FedEx

$250.85 /

-4.29 (-1.68%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$250.85 /

-4.29 (-1.68%)

FDX FedEx
$250.85 /

-4.29 (-1.68%)

09/17/21 UBS
FedEx price target lowered to $380 from $397 at UBS
09/17/21 Baird
FedEx sentiment too negative with favorable outlook, says Baird
09/13/21 KeyBanc
FedEx price target lowered to $350 from $370 at KeyBanc
09/13/21 Citi
FedEx price target lowered to $360 from $365 at Citi
FDX FedEx
$250.85 /

-4.29 (-1.68%)

FDX FedEx
$250.85 /

-4.29 (-1.68%)

FDX FedEx
$250.85 /

-4.29 (-1.68%)

FDX FedEx
$250.85 /

-4.29 (-1.68%)

Conference/Events
Brooklyn ImmunoTherapeutics to hold a conference call » 16:15
09/20/21
09/20
16:15
09/20/21
16:15
BTX

Brooklyn ImmunoTherapeutics

$9.93 /

-2.07 (-17.25%)

Management conducts a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTX Brooklyn ImmunoTherapeutics
$9.93 /

-2.07 (-17.25%)

BTX Brooklyn ImmunoTherapeutics
$9.93 /

-2.07 (-17.25%)

BTX Brooklyn ImmunoTherapeutics
$9.93 /

-2.07 (-17.25%)

BTX Brooklyn ImmunoTherapeutics
$9.93 /

-2.07 (-17.25%)

Hot Stocks
Immuneering to be added to Russell 2000 Index » 16:14
09/20/21
09/20
16:14
09/20/21
16:14
IMRX

Immuneering

$25.79 /

-2.99 (-10.39%)

Immuneering announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMRX Immuneering
$25.79 /

-2.99 (-10.39%)

08/24/21 Morgan Stanley
Immuneering initiated with an Equal Weight at Morgan Stanley
08/24/21 Jefferies
Immuneering initiated with a Buy at Jefferies
08/24/21 Morgan Stanley
Immuneering initiated with an Equal Weight at Morgan Stanley
08/24/21 Jefferies
Immuneering initiated with a Buy at Jefferies
  • 30
    Jul
IMRX Immuneering
$25.79 /

-2.99 (-10.39%)

Hot Stocks
Sportradar announces Michael Jordan as special advisor to board » 16:12
09/20/21
09/20
16:12
09/20/21
16:12
SRAD

Sportradar

$26.25 /

-0.85 (-3.14%)

Sportradar announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 14
    Sep
SRAD Sportradar
$26.25 /

-0.85 (-3.14%)

SRAD Sportradar
$26.25 /

-0.85 (-3.14%)

Hot Stocks
Femasys to join Russell Microcap Index » 16:12
09/20/21
09/20
16:12
09/20/21
16:12
FEMY

Femasys

$6.82 /

-0.43 (-5.93%)

Femasys announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FEMY Femasys
$6.82 /

-0.43 (-5.93%)

FEMY Femasys
$6.82 /

-0.43 (-5.93%)

07/13/21 JonesTrading
Femasys initiated with a Buy at JonesTrading
07/13/21 Chardan
Femasys initiated with a Buy at Chardan
FEMY Femasys
$6.82 /

-0.43 (-5.93%)

Hot Stocks
Great Elm acquires majority interest in Lenders Funding for $7.25M » 16:11
09/20/21
09/20
16:11
09/20/21
16:11
GECC

Great Elm Capital

$3.39 /

+ (+0.00%)

Great Elm Capital …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GECC Great Elm Capital
$3.39 /

+ (+0.00%)

GECC Great Elm Capital
$3.39 /

+ (+0.00%)

04/07/21 Oppenheimer
Great Elm Capital initiated with a Perform at Oppenheimer
GECC Great Elm Capital
$3.39 /

+ (+0.00%)

Hot Stocks
Verrica Pharmaceuticals trading halted, news pending  16:11
09/20/21
09/20
16:11
09/20/21
16:11
VRCA

Verrica Pharmaceuticals

$12.01 /

-0.04 (-0.33%)

 
ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$12.01 /

-0.04 (-0.33%)

VRCA Verrica Pharmaceuticals
$12.01 /

-0.04 (-0.33%)

06/17/21 Needham
Verrica Pharmaceuticals's Ycanth offers superior efficacy to Novan, says Needham
06/01/21 Northland
Verrica Pharmaceuticals price target lowered to $19 from $24 at Northland
05/13/21 RBC Capital
Verrica Pharmaceuticals initiated with an Outperform at RBC Capital
03/08/21 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $24 from $21 at H.C. Wainwright
VRCA Verrica Pharmaceuticals
$12.01 /

-0.04 (-0.33%)

  • 23
    Mar
VRCA Verrica Pharmaceuticals
$12.01 /

-0.04 (-0.33%)

VRCA Verrica Pharmaceuticals
$12.01 /

-0.04 (-0.33%)

Hot Stocks
Alcoa plans restart of aluminum smelting capacity at Alumar in Brazil » 16:10
09/20/21
09/20
16:10
09/20/21
16:10
AA

Alcoa

$48.26 /

-0.59 (-1.21%)

Alcoa announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AA Alcoa
$48.26 /

-0.59 (-1.21%)

AA Alcoa
$48.26 /

-0.59 (-1.21%)

09/16/21 Deutsche Bank
Alcoa price target raised to $60 from $48 at Deutsche Bank
09/15/21
Fly Intel: Top five analyst upgrades
09/15/21 Argus
Alcoa upgraded to Buy from Hold at Argus
09/14/21 Credit Suisse
Alcoa price target raised to $56 from $51 at Credit Suisse
AA Alcoa
$48.26 /

-0.59 (-1.21%)

AA Alcoa
$48.26 /

-0.59 (-1.21%)

AA Alcoa
$48.26 /

-0.59 (-1.21%)

AA Alcoa
$48.26 /

-0.59 (-1.21%)

Hot Stocks
Kilroy Realty signs new leases totaling 330K sqf of office space in San Diego » 16:10
09/20/21
09/20
16:10
09/20/21
16:10
KRC

Kilroy Realty

$64.85 /

-0.36 (-0.55%)

Kilroy Realty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRC Kilroy Realty
$64.85 /

-0.36 (-0.55%)

KRC Kilroy Realty
$64.85 /

-0.36 (-0.55%)

07/14/21 Mizuho
Kilroy Realty assumed with a Neutral at Mizuho
06/25/21 Deutsche Bank
Kilroy Realty price target raised to $65 from $60 at Deutsche Bank
06/16/21 BMO Capital
Austin market entry 'a logical step' for Kilroy Realty, says BMO Capital
06/14/21 Wolfe Research
Kilroy Realty initiated with an Outperform at Wolfe Research
Initiation
Denali Therapeutics initiated with an Outperform at Oppenheimer » 16:08
09/20/21
09/20
16:08
09/20/21
16:08
DNLI

Denali Therapeutics

$49.67 /

-3.15 (-5.96%)

, BIIB

Biogen

$297.90 /

-2.08 (-0.69%)

, SNY

Sanofi

$47.90 /

-0.445 (-0.92%)

, TAK

Takeda Pharmaceutical

$17.05 /

-0.115 (-0.67%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DNLI Denali Therapeutics
$49.67 /

-3.15 (-5.96%)

BIIB Biogen
$297.90 /

-2.08 (-0.69%)

SNY Sanofi
$47.90 /

-0.445 (-0.92%)

TAK Takeda Pharmaceutical
$17.05 /

-0.115 (-0.67%)

DNLI Denali Therapeutics
$49.67 /

-3.15 (-5.96%)

09/01/21 SMBC Nikko
Denali Therapeutics initiated with an Outperform at SMBC Nikko
07/26/21 Stifel
Denali DNL310 data 'noisy and trending in wrong direction,' says Stifel
07/26/21 H.C. Wainwright
Denali Therapeutics price target raised to $105 from $95 at H.C. Wainwright
05/18/21 UBS
Denali Therapeutics initiated with a Buy at UBS
BIIB Biogen
$297.90 /

-2.08 (-0.69%)

04:53 Today Piper Sandler
Neurologist survey shows Aduhelm 'rebounded sharply,' says Piper Sandler
09/16/21 UBS
Biogen price target lowered to $442 from $475 at UBS
09/15/21 BofA
Biogen price target lowered to $360 from $400 at BofA
09/09/21 Morgan Stanley
Morgan Stanley says Biogen challenges suggest low Aduhelm sales until NCD call
SNY Sanofi
$47.90 /

-0.445 (-0.92%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
TAK Takeda Pharmaceutical
$17.05 /

-0.115 (-0.67%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
DNLI Denali Therapeutics
$49.67 /

-3.15 (-5.96%)

BIIB Biogen
$297.90 /

-2.08 (-0.69%)

SNY Sanofi
$47.90 /

-0.445 (-0.92%)

TAK Takeda Pharmaceutical
$17.05 /

-0.115 (-0.67%)

BIIB Biogen
$297.90 /

-2.08 (-0.69%)

SNY Sanofi
$47.90 /

-0.445 (-0.92%)

TAK Takeda Pharmaceutical
$17.05 /

-0.115 (-0.67%)

DNLI Denali Therapeutics
$49.67 /

-3.15 (-5.96%)

BIIB Biogen
$297.90 /

-2.08 (-0.69%)

SNY Sanofi
$47.90 /

-0.445 (-0.92%)

TAK Takeda Pharmaceutical
$17.05 /

-0.115 (-0.67%)

BIIB Biogen
$297.90 /

-2.08 (-0.69%)

TAK Takeda Pharmaceutical
$17.05 /

-0.115 (-0.67%)

Hot Stocks
EDP Renewables, TC Energy execute PPA to add 297MW Alberta wind farm » 16:06
09/20/21
09/20
16:06
09/20/21
16:06
TRP

TC Energy

$47.88 /

-1.25 (-2.54%)

EDP Renewables, through…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$47.88 /

-1.25 (-2.54%)

TRP TC Energy
$47.88 /

-1.25 (-2.54%)

09/13/21 Goldman Sachs
TC Energy downgraded to Neutral from Buy at Goldman Sachs
08/20/21 JPMorgan
TC Energy downgraded to Neutral from Overweight at JPMorgan
08/03/21 National Bank
TC Energy price target lowered to C$66 from C$67 at National Bank
07/20/21 Morgan Stanley
TC Energy downgraded to Equal Weight from Overweight at Morgan Stanley
TRP TC Energy
$47.88 /

-1.25 (-2.54%)

TRP TC Energy
$47.88 /

-1.25 (-2.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.